Newswise — SAN FRANCISCO, CA – January 26, 2023: Glaucoma Research Basis (GRF) President and CEO Thomas M. Brunner announced today that Santen Pharmaceutic Co., Ltd (hereafter, “Santen”), will receive GRF’s highest honor, the Catalyst Award, at the particular Glaucoma 360 Annual Gala on February 2, 2023, in San Francisco.
Santen, a global specialized company focused solely on eye care, is being recognized for their steadfast commitment to bringing innovation to the field of glaucoma. “We are delighted to have an opportunity in order to highlight the Santen team and their own work serving unmet patient needs through their development of innovative solutions to treat glaucoma and improve the quality of life for patients around the particular world, ” said Brunner. Peter Sallstig, MD, MBA, the Global Head of Santen’s Product Development Division and the Chief Medical Officer will accept the particular award on behalf of Santen.
“Santen is extremely proud and honored in order to receive this prestigious award. Our team is guided by a passion for bringing innovation to vision care plus contributing to the well-being associated with patients and their families worldwide. It has been the great pleasure to partner with Glaucoma Research over the particular past 20 years and support their many patient education and research initiatives, ” said Dr . Sallstig.
“Santen aspires to create a world where each person can live their happiest life via the best vision experience and we will continue to help reduce the loss of social and economic opportunities resulting from attention conditions by providing solutions within ophthalmology, by promoting people to pursue eyesight wellness and by creating a society that is inclusive regardless of visual impairment, ” Dr. Sallstig added.
The Annual Gala launches Glaucoma 360, an unique series of events held at the historic Westin St . Francis Hotel that will includes the New Horizons Forum, a full-day meeting dedicated to innovations in glaucoma therapy and concludes with two continuing medical education symposia for ophthalmologists and optometrists. Mr. Brunner added, “Santen has been a generous supporter associated with Glaucoma 360 since our very first meeting within 2012 and has continued to partner with Glaucoma Study Foundation in order to help advance our mission to cure glaucoma plus restore vision through revolutionary research. We are pleased that Dr. Sallstig and numerous Santen group members will certainly join us for this particular special evening. ”
All proceeds from Glaucoma 360 assistance Glaucoma Analysis Foundation’s study and schooling programs. To learn more about the Feb 2–4, 2023, events or to register, visit: www.glaucoma360.org .
About Glaucoma Research Base
Founded in Bay area in 1978, Glaucoma Research Foundation will be America’s oldest and most experienced institution focused on its mission to cure glaucoma and restore vision by means of innovative analysis. The Foundation has a proven track record of pioneering, results-oriented research and produces definitive educational materials used by eye care professionals across the country. The Glaucoma Research Foundation website, www.glaucoma.org , provides valuable information about glaucoma in order to 3 million visitors annually.
About Santen Pharmaceutical
As a specialized company dedicated to eye health, Santen carries out research, advancement, marketing, and sales of pharmaceuticals, over-the-counter products, plus medical devices, and the products now reach individuals in more than 60 countries and regions. Toward realizing “WORLD VISION” (Happiness along with Vision), the particular world Santen ultimately aspires to achieve, as a “Social Innovator, ” Santen aims to reduce the social and economic opportunity loss of people around the world caused by eyes diseases plus defects simply by orchestrating and mobilizing key technologies plus players all over the world. With scientific knowledge and organizational capabilities nurtured more than 130-year history, Santen provides products plus services to contribute in order to the well-being of sufferers, their loved ones and consequently to society. For more information, please visit Santen’s websites: www.santenusa.com (North American headquarters) and www.santen.com (Japan headquarters).
# # #